Related Experiment Video
Updated: Jan 8, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Incidence of and Risk Factors for Laryngopharyngeal Reflux in Patients Undergoing Modified Electroconvulsive Therapy:
Xingying Mo1, Xiaoyue Li2, Tingwei Zheng1
1Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
Background:
Laryngopharyngeal reflux (LPR) is among the most common complications associated with modified electroconvulsive therapy (MECT). The purpose of this study was to assess the prevalence of LPR among patients undergoing MECT and to identify risk factors for LPR within this population.
Methods:
This observational prospective study enrolled 107 consecutive patients who underwent MECT at the Third Affiliated Hospital of Sun Yat-sen University. Data regarding potential risk factors for LPR in patients undergoing MECT were collected. The salivary pepsin test was used to diagnose LPR.
Results:
The incidence of LPR was 39.3% in this study. On univariate analysis, height (p = 0.040), history of acid regurgitation (p = 0.19), number of MECT session number (p = 0.014), succinylcholine dose (p = 0.032), and oral secretion volume (p = 0.01) were significantly associated with LPR. Outcomes from the multivariate analysis are shown as odds ratio (OR [95% confidence interval (CI)]), >3 MECT sessions (3.02 [1.20-7.58]), history of acid regurgitation (3.90 [1.20-12.70]), succinylcholine dose > 50 mg (2.54 [1.04-6.22]), oral secretion volume > 3 mL (3.66 [1.50-8.97]) were significantly and independently associated with the development of LPR.
Conclusion:
A history of acid regurgitation, >3 MECT sessions, succinylcholine dose > 50 mg, oral secretion volume > 3 mL was significantly associated with an increased risk of LPR in patients undergoing MECT.
Insights
Laryngopharyngeal reflux (LPR) affects 39.3% of patients undergoing modified electroconvulsive therapy (MECT). Risk factors include acid regurgitation history, multiple MECT sessions, and higher succinylcholine doses.
Area of Science:
- Neurology
- Gastroenterology
- Psychiatry
Background:
- Laryngopharyngeal reflux (LPR) is a frequent complication of modified electroconvulsive therapy (MECT).
- Understanding LPR prevalence and risk factors in MECT patients is crucial for patient care.
Purpose of the Study:
- To determine the prevalence of LPR in patients undergoing MECT.
- To identify independent risk factors associated with LPR development in this population.
Main Methods:
- An observational prospective study included 107 consecutive patients undergoing MECT.
- The salivary pepsin test was employed for LPR diagnosis.
- Data on potential risk factors were systematically collected.
Main Results:
- The incidence of LPR among MECT patients was 39.3%.
- Multivariate analysis identified significant independent risk factors: >3 MECT sessions (OR 3.02), history of acid regurgitation (OR 3.90), succinylcholine dose > 50 mg (OR 2.54), and oral secretion volume > 3 mL (OR 3.66).
Conclusions:
- A history of acid regurgitation, more than three MECT sessions, a succinylcholine dose exceeding 50 mg, and oral secretion volume greater than 3 mL are significantly associated with an increased risk of LPR in patients undergoing MECT.
Related Concept Videos
Electroconvulsive Therapy
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

